Intelligent Relations
Preston by Intelligent Relations
Nicole Defeudis
Gray shield icon
Is this you?
Claim your profile.

Nicole Defeudis

Editor

AS SEEN ON
Endpoints News, NewsBreak

Preston's Summary

Nicole DeFeudis is an Editor at Endpoints News. She specializes in biopharma reporting, focusing on themes such as pharmaceuticals, healthcare systems, and public health, while also covering legal affairs and litigation within the medical field. Nicole's work has been featured in New England Public Media, World Wealth Journal, and multiple publications under Endpoints News.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

United States (National)

Coverage Attributes:

Beta
Informative: 71 %
Reviews: 13 %
Promotional: 6 %
Opinion: 3 %
Data Driven: 2 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Lawsuits
  • Healthcare Administration
  • Pharmaceutical Manufacturing
  • Pharmaceutical Regulation

Pitching Insights

Nicole's coverage predominantly focuses on the healthcare and pharmaceutical industry, particularly around regulatory approvals, legal policy regulation, and government announcements. She appears to be interested in stories related to FDA approvals, drug pricing, mergers and acquisitions within the pharmaceutical space.

To effectively reach out to Nicole with a pitch or as a source for her articles, it would be beneficial to provide insights or expertise related to recent developments in FDA regulations and approvals, legal challenges faced by pharmaceutical companies such as patent disputes or antitrust issues. Additionally, commentary on the implications of regulatory changes on drug pricing could also resonate well with her coverage focus.

It is important to note that Nicole tends to cover topics without geographic constraints explicitly mentioned. Therefore, pitches should focus on providing broader industry-specific insights rather than region-specific news unless otherwise indicated.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Max Bayer

Max Bayer

Pharma Reporter
*****m@*********om
Publications
Endpoints News, NewsBreak
Most recent topics
Not enough data
Max Gelman

Max Gelman

Senior Editor
**x@**************com
Publications
Endpoints News, orbimed.com
Most recent topics
Not enough data
Lei Lei Wu

Lei Lei Wu

News Reporter
**u@**************com
Publications
Endpoints News
Most recent topics
Not enough data
Elizabeth Cairns

Elizabeth Cairns

Senior biopharma journalist
********hc@**********com
Publications
Endpoints News
Most recent topics
Not enough data
Anna Brown

Anna Brown

News Reporter
*****n@**************com
Publications
Endpoints News, Business NH Magazine, The Tab
Most recent topics
Not enough data
Ayisha Sharma

Ayisha Sharma

News Reporter
******a@********om
Publications
Endpoints News
Most recent topics
Not enough data

Articles

© 2026 Intelligent Relations